Suppr超能文献

改善研究证据在指南制定中的应用:2. 确定优先事项。

Improving the use of research evidence in guideline development: 2. Priority setting.

作者信息

Oxman Andrew D, Schünemann Holger J, Fretheim Atle

机构信息

Norwegian Knowledge Centre for the Health Services, PO Box 7004, St. Olavs plass, N-0130 Oslo, Norway.

出版信息

Health Res Policy Syst. 2006 Nov 29;4:14. doi: 10.1186/1478-4505-4-14.

Abstract

BACKGROUND

The World Health Organization (WHO), like many other organisations around the world, has recognised the need to use more rigorous processes to ensure that health care recommendations are informed by the best available research evidence. This is the second of a series of 16 reviews that have been prepared as background for advice from the WHO Advisory Committee on Health Research to WHO on how to achieve this.

OBJECTIVES

We reviewed the literature on priority setting for health care guidelines, recommendations and technology assessments.

METHODS

We searched PubMed and three databases of methodological studies for existing systematic reviews and relevant methodological research. We did not conduct systematic reviews ourselves. Our conclusions are based on the available evidence, consideration of what WHO and other organisations are doing and logical arguments.

KEY QUESTIONS AND ANSWERS

There is little empirical evidence to guide the choice of criteria and processes for establishing priorities, but there are broad similarities in the criteria that are used by various organisations and practical arguments for setting priorities explicitly rather than implicitly, WHAT CRITERIA SHOULD BE USED TO ESTABLISH PRIORITIES?: WHO has limited resources and capacity to develop recommendations. It should use these resources where it has the greatest chance of improving health, equity, and efficient use of healthcare resources. We suggest the following criteria for establishing priorities for developing recommendations based on WHO's aims and strategic advantages: Problems associated with a high burden of illness in low and middle-income countries, or new and emerging diseases. No existing recommendations of good quality. The feasibility of developing recommendations that will improve health outcomes, reduce inequities or reduce unnecessary costs if they are implemented. Implementation is feasible, will not exhaustively use available resources, and barriers to change are not likely to be so high that they cannot be overcome. Additional priorities for WHO include interventions that will likely require system changes and interventions where there might be a conflict in choices between individual and societal perspectives. WHAT PROCESSES SHOULD BE USED TO AGREE ON PRIORITIES?: The allocation of resources to the development of recommendations should be part of the routine budgeting process rather than a separate exercise. Criteria for establishing priorities should be applied using a systematic and transparent process. Because data to inform judgements are often lacking, unmeasured factors should also be considered--explicitly and transparently. The process should include consultation with potential end users and other stakeholders, including the public, using well-constructed questions, and possibly using Delphi-like procedures. Groups that include stakeholders and people with relevant types of expertise should make decisions. Group processes should ensure full participation by all members of the group. The process used to select topics should be documented and open to inspection. SHOULD WHO HAVE A CENTRALISED OR DECENTRALISED PROCESS?: Both centralised and decentralised processes should be used. Decentralised processes can be considered as separate "tracks". Separate tracks should be used for considering issues for specific areas, populations, conditions or concerns. The rationales for designating special tracks should be defined clearly; i.e. why they warrant special consideration. Updating of guidelines could also be considered as a separate "track", taking account of issues such as the need for corrections and the availability of new evidence.

摘要

背景

世界卫生组织(WHO)与世界上许多其他组织一样,认识到需要采用更严谨的流程,以确保医疗保健建议以现有最佳研究证据为依据。这是为WHO健康研究咨询委员会向WHO提供关于如何实现这一目标的建议而准备的16篇综述系列中的第二篇。

目的

我们回顾了关于医疗保健指南、建议和技术评估的优先事项设定的文献。

方法

我们在PubMed和三个方法学研究数据库中搜索现有的系统综述和相关的方法学研究。我们自己没有进行系统综述。我们的结论基于现有证据、对WHO和其他组织正在开展的工作的考量以及合理的论证。

关键问题与答案

几乎没有实证证据可指导确定优先事项的标准和流程的选择,但不同组织使用的标准存在广泛相似之处,并且有实际理由明确而非隐含地设定优先事项。应使用哪些标准来确定优先事项?:WHO用于制定建议的资源和能力有限。它应将这些资源用于最有可能改善健康、公平性以及医疗资源有效利用的地方。基于WHO的目标和战略优势,我们建议以下确定制定建议的优先事项的标准:与低收入和中等收入国家高疾病负担相关的问题,或新出现的疾病。没有高质量的现有建议。如果实施,制定能够改善健康结果、减少不公平现象或降低不必要成本的建议的可行性。实施是可行的,不会耗尽可用资源,并且变革的障碍不太可能高到无法克服。WHO的其他优先事项包括可能需要系统变革的干预措施以及在个人和社会观点之间的选择可能存在冲突的干预措施。应使用哪些流程来就优先事项达成一致?:为制定建议分配资源应作为常规预算编制过程的一部分,而不是一项单独的工作。应使用系统且透明的流程来应用确定优先事项的标准。由于往往缺乏用于做出判断的数据,还应明确且透明地考虑未衡量的因素。该流程应包括使用精心构建的问题与潜在终端用户和其他利益相关者(包括公众)进行协商,可能采用类似德尔菲法的程序。应让包括利益相关者和具有相关专业知识类型的人员的团体做出决策。团体流程应确保团体所有成员充分参与。用于选择主题的流程应记录在案并接受检查。WHO应采用集中式还是分散式流程?:应同时使用集中式和分散式流程。分散式流程可视为单独的“轨道”。应使用单独的轨道来考虑特定领域、人群、病症或关注点的问题。应明确界定指定特殊轨道的理由,即为什么它们值得特别考虑。指南的更新也可视为一个单独的“轨道”,同时考虑诸如需要更正以及新证据的可用性等问题。

相似文献

1
Improving the use of research evidence in guideline development: 2. Priority setting.
Health Res Policy Syst. 2006 Nov 29;4:14. doi: 10.1186/1478-4505-4-14.
2
Improving the use of research evidence in guideline development: 16. Evaluation.
Health Res Policy Syst. 2006 Dec 8;4:28. doi: 10.1186/1478-4505-4-28.
5
Improving the use of research evidence in guideline development: 14. Reporting guidelines.
Health Res Policy Syst. 2006 Dec 8;4:26. doi: 10.1186/1478-4505-4-26.
8
Improving the use of research evidence in guideline development: 7. Deciding what evidence to include.
Health Res Policy Syst. 2006 Dec 1;4:19. doi: 10.1186/1478-4505-4-19.

引用本文的文献

3
Prioritization approaches in the development of health practice guidelines: a systematic review.
BMC Health Serv Res. 2019 Oct 15;19(1):692. doi: 10.1186/s12913-019-4567-2.
4
Scoping literature review on the basic health benefit package and its determinant criteria.
Global Health. 2018 Mar 2;14(1):26. doi: 10.1186/s12992-018-0345-x.
6
Public health policies and scientific evidence.
Einstein (Sao Paulo). 2017 Oct-Dec;15(4):7-10. doi: 10.1590/S1679-45082017ED4314.
9
Research prioritization of men's health and urologic diseases.
Int Braz J Urol. 2017 Mar-Apr;43(2):289-303. doi: 10.1590/S1677-5538.IBJU.2016.0047.
10
An approach for setting evidence-based and stakeholder-informed research priorities in low- and middle-income countries.
Bull World Health Organ. 2016 Apr 1;94(4):297-305. doi: 10.2471/BLT.15.162966. Epub 2015 Feb 12.

本文引用的文献

2
Improving the use of research evidence in guideline development: 5. Group processes.
Health Res Policy Syst. 2006 Dec 1;4:17. doi: 10.1186/1478-4505-4-17.
3
Improving the use of research evidence in guideline development: introduction.
Health Res Policy Syst. 2006 Nov 20;4:12. doi: 10.1186/1478-4505-4-12.
4
Can the value choices in DALYs influence global priority-setting?
Health Policy. 2004 Nov;70(2):137-49. doi: 10.1016/j.healthpol.2003.08.004.
5
Involving the general public in priority setting: experiences from Australia.
Soc Sci Med. 2003 Mar;56(5):1001-12. doi: 10.1016/s0277-9536(02)00091-6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验